Zobrazeno 1 - 10
of 33
pro vyhledávání: '"B S, Charak"'
Publikováno v:
Bone marrow transplantation. 15(5)
Ceftazidime has been reported to cause myelosuppression both in vitro and in vivo. Granulocyte colony-stimulating factor (G-CSF) is known to enhance the proliferation and differentiation of myeloid cells. The present study was carried out to define t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c058938125465e02d21b00efa09505f8
https://pubmed.ncbi.nlm.nih.gov/7545489
https://pubmed.ncbi.nlm.nih.gov/7545489
Publikováno v:
Cancer treatment and research. 76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9eb8cba2bf0db1bb5a442a10e53fd0d3
https://pubmed.ncbi.nlm.nih.gov/7577342
https://pubmed.ncbi.nlm.nih.gov/7577342
Publikováno v:
Blood. 81(12)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been reported to induce antitumor activity in peripheral blood monocytes. We examined the role of GM-CSF on bone marrow (BM) macrophages in inducing antibody-dependent cellular cytotoxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a2558ea95c46854b9c2a5762d34f441
https://pubmed.ncbi.nlm.nih.gov/8507882
https://pubmed.ncbi.nlm.nih.gov/8507882
Autor:
B S, Charak
Publikováno v:
The National medical journal of India. 6(1)
Interleukin-2 results in the generation of lymphokine activated killer cells which exhibit a potent effect against a wide variety of tumours. Consequently, interleukin-2 therapy has been used to induce a graft versus tumour effect following autologou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30e9fae2bf96c53a4207585d17afe674
https://pubmed.ncbi.nlm.nih.gov/8453356
https://pubmed.ncbi.nlm.nih.gov/8453356
Publikováno v:
Cancer research. 52(23)
Interferon (IFN) increases the expression of major histocompatibility (MHC) antigens on the surface of tumor cells. Cyclosporine A (CsA) administration following myeloablative therapy and syngeneic bone marrow transplantation results in the generatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58deda81bd2ac564bd7a18098b1bcce2
https://pubmed.ncbi.nlm.nih.gov/1384963
https://pubmed.ncbi.nlm.nih.gov/1384963
Publikováno v:
Bone marrow transplantation. 10(2)
Interleukin-2 (IL-2) promotes the generation and proliferation of killer cells in the peripheral blood and bone marrow (BM) both in vitro and in vivo. When employed in a syngeneic bone marrow transplantation (BMT) setting and followed by IL-2 therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e83a6beef5a904109756895e6340177c
https://pubmed.ncbi.nlm.nih.gov/1326364
https://pubmed.ncbi.nlm.nih.gov/1326364
Publikováno v:
Blood. 80(1)
Interleukin-2 (IL-2) therapy generates killer cells with major histocompatibility complex (MHC)-unrestricted cytotoxicity against most tumors but not normal tissues. Cyclosporine A (CsA) has been reported to break tolerance to self and to induce kill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7bf79312d1a76855a730a6c549cc919a
https://pubmed.ncbi.nlm.nih.gov/1611084
https://pubmed.ncbi.nlm.nih.gov/1611084
Publikováno v:
Bone marrow transplantation. 9(6)
Incubation of bone marrow (BM) with interleukin-2 (IL-2) in vitro results in generation of killer cells providing a tool for enhancing the graft-versus-tumor effect in transplantation. We have evaluated the influence of IL-2 on the progenitor cell ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d263ef3a2b908f9b61c9750d8596b57e
https://pubmed.ncbi.nlm.nih.gov/1628133
https://pubmed.ncbi.nlm.nih.gov/1628133
Publikováno v:
Indian journal of cancer. 28(2)
Twenty-five patients with acute nonlymphoblastic leukemia undergoing 41 cycles of chemotherapy with daunorubicin/cytosine arabinoside (ara-C) or with etoposide/ara-C received metoclopramide (MCP; 0.5 mg/kg 6 hourly i.v.) or MCP (same dose) plus oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4618a22caf5b5dccc76ed13b00eb5a44
https://pubmed.ncbi.nlm.nih.gov/1937545
https://pubmed.ncbi.nlm.nih.gov/1937545
Publikováno v:
Cancer research. 51(10)
Low uptake of monoclonal antibodies (MAbs) in cancer lesions is a significant problem in cancer therapy. Recent studies have shown that antibody uptake in tumor is controlled in large part by the tumor blood flow and the vascular permeability of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::640baa5ab510f001b0013410a8110b4e
https://pubmed.ncbi.nlm.nih.gov/2021947
https://pubmed.ncbi.nlm.nih.gov/2021947